Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia-Reference-Cited by-同舟云学术

Clinical Pharmacology of Tisagenlecleucel in B-cell Acute Lymphoblastic Leukemia

Published:2018-09-06 Issue:24 Volume:24 Page:6175-6184
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Mueller Karen Thudium,Waldron Edward,Grupp Stephan A.,Levine John E.^ORCID,Laetsch Theodore W.,Pulsipher Michael A.,Boyer Michael W.,August Keith J.^ORCID,Hamilton Jason,Awasthi Rakesh,Stein Andrew M.,Sickert Denise,Chakraborty Abhijit,Levine Bruce L.^ORCID,June Carl H.,Tomassian Lori,Shah Sweta S.,Leung Mimi,Taran Tetiana,Wood Patricia A.,Maude Shannon L.

Funder

Novartis Pharmaceuticals Corporation (NPC)

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 182 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering potent chimeric antigen receptor T cells by programming signaling during T-cell activation;Scientific Reports;2024-09-12

2. Chimeric antigen receptor T‐cell therapy for haematological malignancies: Insights from fundamental and translational research to bedside practice;British Journal of Haematology;2024-09-11

3. Functional Activity of Cytokine-Induced Killer Cells Enhanced by CAR-CD19 Modification or by Soluble Bispecific Antibody Blinatumomab;Antibodies;2024-08-30

4. Getting the Dose Right in Drug Development for Rare Diseases: Barriers and Enablers;Clinical Pharmacology & Therapeutics;2024-08-16

5. Model-informed drug development in pediatric, pregnancy and geriatric drug development: States of the art and future;Advanced Drug Delivery Reviews;2024-08